Other studies also demonstrated that SFAs indeed can activate Toll-like receptor 4-(TLR4-) and TLR2-mediated pro-inflammatory signaling pathways and consequently increase the risk of insulin resistance (48). The gene discussed is TLR2; the disease is Insulin resistance.